• Stampa
Valutazione attuale:  / 3

PubbliTesi - La Tesi
Evaluating the consequences of reimbursing malaria chemoprophylaxis to travelers departing from metropolitan France to highly endemic areas of sub-Saharan Africa: A cost effectiveness analysis

Scheda Sintetica

Autore: Camilla Fiorina
Relatore: Davide Vannoni
Università: Università degli Studi di Torino
Facoltà: Dipartimento Scienze economico-sociali e matematico-statistiche
Corso: Corso di Laurea magistrale in Economics
Data di Discussione: 16/03/2021
Voto: 110 cum laude
Disciplina: Health Economics
Tipo di Tesi: Di Ricerca
Altri Relatori: Jean-Michel Josselin, Emma Bajeux
Lingua: Inglese
Grande Area: Area Sociale
Dignità di Stampa: Si
Settori Interessati: Pharmaceutical, HTA

Despite annually adapted recommendations for travelers to malaria endemic destinations, France is the Western country with the highest number of imported malaria cases. The present study evaluates the consequences of partially reimbursing the cost of the three recommended drugs for malaria chemoprophylaxis (CP) to travelers heading to endemic regions in sub-Saharan Africa (SSA), which is currently fully borne by travelers. This is done by performing a cost-effectiveness analysis (CEA) from the perspective of the French National Health Insurance (NHI) of three strategies of 65% CP reimbursement, compared to the current strategy of non-reimbursement. The study concludes that reimbursing malaria CP would have a positive effect on malaria prevention in France, especially when it is targeted to groups of travelers at high risk for malaria. In this regard, results of the CEA constitute a further element that can be taken into account by policy makers when assessing the relevance of a similar ...

Grado di Innovazione:
To my knowledge, this study was the first to explore the outcomes of three different reimbursement strategies, particularly by assessing the consequences of allowing the reimbursement to travelers visiting friends and relatives exclusively. The results of our analysis, and in particular the net and incremental cost of the different reimbursement strategies, constitute a further element that can be taken into account in assessing the financial impact of the prevention policy. Moreover, analyzing ...